Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Joe E. who wrote (5334)	9/18/1998 3:50:00 PM
From: Steve Fancy	Respond to of 6136

Joe, you may be right...based on the quick jump in volume and price, looks like some significant short covering. sf

To: Joe E. who wrote (5334)	9/18/1998 3:51:00 PM
From: biodoc	Read Replies (1) \| Respond to of 6136

I think it is more likely to be potential for information regarding the usefulness of nelfinivir in combination with Sustiva to be presented at ICAAC that is doing it--AGPH will ride the coattails.